The clinical performance is complex and often involves multi-systematic stress. Early identification and standardized clinical care are essential for improving prognosis. The diagnosis of the disease requires a combination of clinical performance, imaging, laboratory testing and pathological evaluation.
The platform can assist in matching a team of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. Treatment and management of Sotos syndrome requires individual development, usually including multidimensional management of drug therapy, rehabilitation interventions, regular follow-up, etc. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many previously difficult-to-treat genetic metabolic disorders have been significantly improved.
Treatment requires close monitoring of therapeutic effects and adverse reactions, with timely adjustment according to changes in the disease. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of the overgrowth associated with Sotos syndrome. The platform serves a team of domestic and foreign experts in the field of genetic metabolism in China's international medical service system, providing the following services to patients: 2.
Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.